您的位置: 首页 > 农业专利 > 详情页

ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
专利权人:
POLARIS GROUP
发明人:
SHOWALTER, RICHARD E.,THOMSON, JAMES A.,ALMASSY, ROBERT,SISSON, WES,SHIA, WEI-JONG,CHEN, LI-CHANG,YANG, LEE
申请号:
SG11201507354Q
公开号:
SG11201507354QA
申请日:
2014.03.13
申请国别(地区):
SG
年份:
2015
代理人:
摘要:
The present invention relates generally to isolated to arginine deiminase (ADI) proteins that have reduced cross-reactivity with anti-ADI-PEG 20 antibodies as compared to ADI-PEG 20, but which can have functional characteristics comparable to or better than ADI-PEG 20, compositions comprising the ADI proteins, and related methods of treating arginine-dependent diseases or related diseases such as cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充